Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes

scientific article

Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.0000092886.52404.50
P698PubMed publication ID14517165

P50authorSean HesselbacherQ57240738
Klaus F. LeyQ89016809
Ian J. SarembockQ106705959
P2093author name stringMeng Chen
John M Sanders
Zandong Yang
Jerry Nadler
Kurt G Barringhaus
Ann C Czarnik
J William Phillips
P433issue16
P407language of work or nameEnglishQ1860
P921main subject(RS)-rosiglitazoneQ424771
type 2 diabetesQ3025883
P304page(s)1994-1999
P577publication date2003-09-29
P1433published inCirculationQ578091
P1476titleRosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes
P478volume108